in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Hovione and Particle Sciences Sign Deal for Drug Solubilization Projects
7:10 AM MDT | June 14, 2011 | Deepti Ramesh
Active pharmaceutical ingredients (API) manufacturer Hovione (Loures, Portugal) says it has signed a collaboration agreement with Particle Sciences Inc. (PSI; Bethlehem, PA) to pool their technologies together for projects targeting poorly water soluble drugs. Hovione and PSI are joining their solid solution technologies based on spray-drying capabilities and targeting ways to maximize the bioavailability of BCS Class II APIs. PSI will develop the solubilization process and resulting drug product for their clients and Hovione managing the scale-up and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee